Clinical Study

The Effects of Vitamin E and Omega-3 PUFAs on Endothelial Function among Adolescents with Metabolic Syndrome

Table 1

Anthropometric and biochemical parameters in the three study groups.

Variable Vitamin E group 
(n = 30)
Omega-3 group 
(n = 26)
Placebo group 
(n = 27)
P value

Sex (men/women) %46.2/53.866.7/33.374.1/25.90.841
Mean age (year)16.15 ± 1.8917.14 ± 2.8216.63 ± 2.390.589
Weight (baseline), kg65.82 ± 17.3557.08 ± 14.2267.02 ± 18.790.071
Weight (final), kg67.28 ± 16.8558.46 ± 13.6370.14 ± 18.190.033
P value0.069<0.0010.001
Height (baseline), cm153.40 ± 11.13148.98 ± 10.24156.15 ± 12.460.073
Height (final), cm154.70 ± 11.24151.85 ± 9.82158.04 ± 12.030.073
P value<0.001<0.0010.001
Waist circumference (baseline), cm93.87 ± 10.8889.50 ± 8.7795.44 ± 12.500.303
Waist circumference (final), cm95.04 ± 11.2389.54 ± 8.4297.08 ± 11.670.341
P value0.7540.9320.225
Cholesterol (baseline), mg/dL183.27 ± 47.46178.68 ± 38.07197.50 ± 33.410.248
Cholesterol (total), mg/dL192.00 ± 44.46195.11 ± 42.61192.83 ± 32.600.978
P value0.5630.5080.833
Triglyceride (baseline), mg/dL179.63 ± 99.19162.36 ± 59.78218.62 ± 111.870.111
Triglyceride (total), mg/dL197.80 ± 63.00165.87 ± 87.58198.49 ± 49.980.279
P value0.4470.9980.129
HDL (baseline), mg/dL38.00 ± 8.5539.16 ± 10.6733.21 ± 3.390.066
HDL (total), mg/dL40.80 ± 7.6344.06 ± 5.9437.17 ± 3.930.007
P value0.3030.2760.068
LDL (baseline), mg/dL103.96 ± 26.47107.20 ± 28.27119.83 ± 26.210.128
LDL (total), mg/dL116.20 ± 42.46123.22 ± 47.26125.55 ± 31.820.870
P value0.4380.1770.226
Fasting blood sugar (baseline), mg/dL90.40 ± 22.3088.84 ± 8.0581.30 ± 8.710.089
Fasting blood sugar (total), mg/dL85.70 ± 11.2799.37 ± 37.4380.33 ± 4.420.146
P value0.6440.3460.641